Zobrazeno 1 - 10 of 827 pro vyhledávání: '"San José G"'
1
Akademický článek
Circulating biomarkers of myocardial remodelling: current developments and clinical applications.
Autor: López B; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., Ravassa S; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., San José G; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., Latasa I; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., Losada-Fuentenebro B; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain., Tapia L; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain., Díez J; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; CIBERCV, Madrid, Spain., Bayés-Genís A; CIBERCV, Madrid, Spain.; University Hospital Germans Trias i Pujol and Universitat Autònoma de Barcelona, Badalona, Spain., González A; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain amiqueo@unav.es.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain.; Department of Cardiology, Clínica Univarsidad de Navarra, Pamplona, Spain.
Publikováno v: Heart (British Cardiac Society) [Heart] 2024 Sep 16; Vol. 110 (19), pp. 1157-1163. Date of Electronic Publication: 2024 Sep 16.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management.
Autor: González A; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Department of Pathology, Anatomy and Physiology, Universidad de Navarra, Pamplona, Spain (A.G.)., López B; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., Ravassa S; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., San José G; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., Latasa I; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., Butler J; Baylor Scott and White Research Institute, Dallas, TX (J.B.).; Department of Medicine, University of Mississippi, Jackson (J.B.)., Díez J; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).
Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Feb; Vol. 81 (2), pp. 218-228. Date of Electronic Publication: 2023 Dec 12.
Zobrazit plný text záznamu
4
Akademický článek
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies.
Autor: Ravassa S; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., López B; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Treibel TA; Institute of Cardiovascular Science, University College London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK., San José G; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Losada-Fuentenebro B; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Tapia L; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Bayés-Genís A; CIBERCV, Carlos III Institute of Health, Madrid, Spain; Servei de Cardiologia i Unitat d'Insuficiència Cardíaca, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; ICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain., Díez J; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain. Electronic address: jadimar@unav.es., González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain. Electronic address: amiqueo@unav.es.
Publikováno v: Molecular aspects of medicine [Mol Aspects Med] 2023 Oct; Vol. 93, pp. 101194. Date of Electronic Publication: 2023 Jun 27.
Zobrazit plný text záznamu
5
Akademický článek
Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides.
Autor: Ravassa S; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain. Electronic address: sravassa@unav.es., Lupón J; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain; Cardiology Service and Cardiac Insufficiency Unit, Germans Trias i Pujol University Hospital, Badalona, Spain; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain., López B; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain., Codina P; Cardiology Service and Cardiac Insufficiency Unit, Germans Trias i Pujol University Hospital, Badalona, Spain., Domingo M; Cardiology Service and Cardiac Insufficiency Unit, Germans Trias i Pujol University Hospital, Badalona, Spain., Revuelta-López E; Heart Failure and Cardiac Regeneration (ICREC) Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain., Moreno MU; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain., San José G; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain., Santiago-Vacas E; Cardiology Service and Cardiac Insufficiency Unit, Germans Trias i Pujol University Hospital, Badalona, Spain., Cediel G; Cardiology Service and Cardiac Insufficiency Unit, Germans Trias i Pujol University Hospital, Badalona, Spain., Roncal C; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain., Díez J; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain., Bayés-Genís A; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain; Cardiology Service and Cardiac Insufficiency Unit, Germans Trias i Pujol University Hospital, Badalona, Spain; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain; Heart Failure and Cardiac Regeneration (ICREC) Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain., González A; Program of Cardiovascular Diseases, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Network Center for Biomedical Research into Cardiovascular Diseases (CIBERCV), Carlos III Institute of Health, Madrid, Spain. Electronic address: amiqueo@unav.es.
Publikováno v: JACC. Heart failure [JACC Heart Fail] 2023 Jan; Vol. 11 (1), pp. 58-72. Date of Electronic Publication: 2022 Nov 09.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Quantification of Replacement Fibrosis in Aortic Stenosis: A Narrative Review on the Utility of Cardiovascular Magnetic Resonance Imaging.
Autor: Rajah, Megan R.1 (AUTHOR) 16607031@sun.ac.za, Doubell, Anton F.1 (AUTHOR), Herbst, Philip G.1 (AUTHOR)
Publikováno v: Diagnostics (2075-4418). Nov2024, Vol. 14 Issue 21, p2435. 15p.
Zobrazit plný text záznamu
9
Akademický článek
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action.
Autor: Romero-González G; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Ravassa S; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain., González O; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Lorenzo I; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Rojas MA; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., García-Trigo I; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., García-Fernández N; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Lavilla J; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Martín PL; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., López B; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain., González A; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain., Beaumont FJ; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain., San José G; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain., Moreno MU; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain., Ania N; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Osacar E; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Amézqueta P; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain., Díez J; Departamento de Nefrología, Clínica Universidad de Navarra, Pamplona, Spain; Programa de Enfermedades Cardiovasculares, Centro de Investigación Médica Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de las Enfermedades Cardiovasculares, CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigación Sanitaria de Navarra, IDISNA, Pamplona, Spain; Departamento de Cardiología y Cirugía Cardiaca, Clínica Universidad de Navarra, Pamplona, Spain. Electronic address: jadimar@unav.es.
Publikováno v: Nefrologia [Nefrologia (Engl Ed)] 2020 May - Jun; Vol. 40 (3), pp. 223-236. Date of Electronic Publication: 2019 Dec 31.
Zobrazit plný text záznamu
10
Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure.
Autor: Beaumont J; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain., López B; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain., Ravassa S; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain., Hermida N; Institute of Experimental and Clinical Research, University of Louvain (UCL) Medical School, B-1200, Brussels, Belgium., San José G; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain., Gallego I; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain., Valencia F; Division of Cardiology, Virgen de la Victoria University Hospital, 29010, Málaga, Spain., Gómez-Doblas JJ; Division of Cardiology, Virgen de la Victoria University Hospital, 29010, Málaga, Spain., de Teresa E; Division of Cardiology, Virgen de la Victoria University Hospital, 29010, Málaga, Spain., Díez J; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain. jadimar@unav.es.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain. jadimar@unav.es.; Department of Cardiology and Cardiovascular Surgery, University of Navarra Clinic, 31008, Pamplona, Spain. jadimar@unav.es., González A; Program of Cardiovascular Diseases, Centre for Applied Medical Research, University of Navarra, 31008, Pamplona, Spain. amiqueo@unav.es.; IdiSNA, Navarra Institute for Health Research, 31008, Pamplona, Spain. amiqueo@unav.es.
Publikováno v: Scientific reports [Sci Rep] 2020 Apr 16; Vol. 10 (1), pp. 6703. Date of Electronic Publication: 2020 Apr 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje